Quivadla Trademark Details

This mark is alive with a status of Suspension Letter - Mailed. The last case file activity for this mark occured 7 years ago on Wednesday, June 8, 2016, according to the United State Patent & Trademark Office
Word Mark Quivadla
Status Alive 653 — Suspension Letter - Mailed
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Serial Number 86965116
Status Date Wednesday, June 8, 2016
Filing Date Wednesday, June 8, 2016
Attorney Heather A. McDonald

Correspondent

HEATHER A. MCDONALD
PFIZER INC.
235 EAST 42ND ST.
NEW YORK, NY 10017

Case File Statements

Goods & Services Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, April 11, 2016
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.